Company / Shares Outstanding
Co-Diagnostics, Inc. Shares Outstanding History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
1.1M
FY2025
5-year range
1.1M / 33.8M
FY2021-FY2025
Trend
-96.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shares Outstanding has fluctuated over the past 9 years, ranging from 1101785.00 in FY2025 to 33819862.00 in FY2022.
Based on SEC 10-K filings.
1101785.00 in FY2025 with a 5-year CAGR of -42.4%.
Improved from 30872607.00 to 1101785.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -68.1%
- 5-Year CAGR
- -42.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, shares outstanding decreased 96.5% year-over-year.
- Peak shares outstanding was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 1.1M | -96.5% |
| FY2024 | 31.3M | +1.3% |
| FY2023 | 30.9M | -8.7% |
| FY2022 | 33.8M | +18.4% |
| FY2021 | 28.6M | +64.7% |
| FY2020 | 17.3M | +34.2% |
| FY2019 | 12.9M | +4.9% |
| FY2018 | 12.3M | +24.6% |
| FY2017 | 9.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026